IBM AI Stock Analysis – Buy, Hold, or Avoid?

5 left

International Business Machines Corporation (IBM)

$230.76-6.42 (-2.71%) today

Open
$239.19
High
$239.27
Low
$230.51
Volume
4.65M
Mkt Cap
$216.46B
52W High
$324.90
AI Verdict
Confidence 86%
IBMInternational Business Machines Corporation
AlphaCrew AI
HOLD
Overall
Summary

IBM offers strong long-term fundamentals and improving profitability, but current technicals are bearish and valuation is fair rather than compelling. While the company is well-positioned for AI and hybrid cloud growth, near-term downside risk remains due to negative price momentum and liquidity concerns. Investors should monitor for technical stabilization or a more attractive entry point before adding exposure.

By Timeframe
Hover for details
WAIT
Short
HOLD
Medium
BUY
Long
Agent Signals
41
Fund
Tech
Val
Sent
Risk

Fundamentals

Essentia
Essentia
Fundamental Analysis
NEUTRAL

IBM demonstrates solid financial fundamentals with improving profitability, consistent revenue growth, and recurring earnings beats, underpinned by its strategic focus on hybrid cloud and AI. While shares have come off their highs, operational execution and margin expansion support a constructive view, though valuation is full relative to its growth.

Financial Highlights

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025$0$5.0B$10.0B$15.0B$20.0BRevenue & Net Income ($)6%12%18%24%30%Net Margin (%)
  • Revenue
  • Net Income
  • Net Margin (%)

Revenue

$19.69B

12.15% YoY

Q4 2025

Net Income

$5.60B

92.18% YoY

Q4 2025

Net Margin

28.45%

Q4 2025

Growth Metrics

Revenue Growth YoY

12.15%

Latest Quarter: Q4 2025

Net Income Growth YoY

92.18%

Latest Quarter: Q4 2025

Revenue Per Share Growth YoY

10.89%

Latest Quarter: Q4 2025

EPS Growth YoY

89.84%

Latest Quarter: Q4 2025

Book Value Per Share Growth YoY

18.18%

Latest Quarter: Q4 2025

 Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Revenue19.7B16.3B17.0B14.5B17.6B15.0B15.8B14.5B
Revenue Growth YoY+12.15%+9.11%+7.66%+0.55%+1.00%+1.46%+1.90%+1.47%
Net Income5.6B1.7B2.2B1.1B2.9B-330.0M1.8B1.6B
Net Income Growth YoY+92.18%+628.48%+19.63%-34.27%-11.37%-119.37%+15.86%+73.14%
EPS$5.98$1.87$2.36$1.14$3.15-$0.36$1.99$1.75
EPS Growth YoY+89.84%+619.44%+18.59%-34.86%-12.26%-119.25%+14.37%+71.57%

Profitability Metrics

Gross Margin

59.50%

TTM

Operating Margin

15.29%

TTM

Net Margin

15.69%

TTM

Return on Equity

36.86%

TTM

Return on Assets

14.56%

TTM

 Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Gross Margin61.56%58.73%58.77%55.23%59.47%56.26%56.76%53.54%
Operating Margin21.16%16.29%18.18%12.14%22.22%14.55%15.44%10.81%
Net Margin28.45%10.68%12.92%7.26%16.60%-2.20%11.63%11.10%
Return on Equity (ROE)17.15%6.25%7.98%3.92%10.67%-1.35%7.63%6.90%
Return on Assets (ROA)7.70%2.60%3.19%1.57%4.43%-0.53%2.86%2.40%

Technical Analysis

Candela
Candela
Technical Analysis
BEARISH

IBM is currently in a pronounced downtrend with price trading well below key moving averages and exhibiting a death cross. Momentum indicators show a neutral RSI but the overall technical stance is bearish, with weak trend strength, suggesting cautious trading. The stock is in Stage 4, the declining phase, indicating further downside risk unless a clear basing pattern emerges.

RSI
Hold
Neutral35

No extreme reading

03070100
Trend
Sell
Strong Downtrend

Price in downtrend

-16.5% from 200 SMA
ADX
Hold
Weak/No Trend19

Range-bound market

Weak
MA Cross
Sell
Below 50/200

50 below 200 - bearish

50
200

Key Technical Values

Price
$230.76
50 SMA
$256.34
150 SMA
$280.93
200 SMA
$276.43
52W High
$324.90
52W Low
$215.16

Price with Moving Averages

50-day, 150-day and 200-day simple moving averages

Price
50 SMA
150 SMA
200 SMA

Relative Strength Index

Momentum oscillator measuring speed and magnitude of price changes

RSI (14)

≤30 Oversold
≥70 Overbought
35Neutral

Earnings

Essentia
Essentia
Fundamental Analysis
NEUTRAL

IBM demonstrates solid financial fundamentals with improving profitability, consistent revenue growth, and recurring earnings beats, underpinned by its strategic focus on hybrid cloud and AI. While shares have come off their highs, operational execution and margin expansion support a constructive view, though valuation is full relative to its growth.

Latest Earnings

Q4 2025 Earnings (Dec 31, 2025)

Earnings Per Share (EPS)

Beat

Actual

$4.52

Estimated

$4.31

Surprise

+$0.21

Surprise %

+4.87%

Revenue

Beat

Actual

$19.69B

Estimated

$19.19B

Surprise

+$495.76M

Surprise %

+2.58%

Historical Earnings

 Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Earnings Per Share
EPS (Actual)$4.52$2.65$2.80$1.60$3.92$2.30$2.43$1.68
EPS (Estimated)$4.31$2.45$2.65$1.42$3.77$2.22$2.20$1.60
EPS Surprise+$0.21+$0.20+$0.15+$0.18+$0.15+$0.08+$0.23+$0.08
% Diff+4.9%+8.2%+5.7%+12.7%+4.0%+3.6%+10.5%+5.0%
Revenue
Revenue (Actual)$19.69B$16.33B$16.98B$14.54B$17.55B$14.97B$15.77B$14.46B
Revenue (Estimated)$19.19B$16.09B$16.59B$14.39B$17.56B$15.08B$15.62B$14.55B
Revenue Surprise+$495.76M+$238.33M+$388.29M+$151.02M-$5.12M-$110.78M+$145.79M-$89.7M
% Diff+2.6%+1.5%+2.3%+1.0%-0.0%-0.7%+0.9%-0.6%

Valuation

Valorem
Valorem
Valuation Analysis
FAIRLY VALUED

IBM currently trades at a fairly moderate valuation relative to its long-term history and peers in the technology sector. While showing solid financial metrics and improving earnings growth, the stock is positioned with mixed market sentiment but with a general analyst bias towards moderate buy ratings and price targets implying a notable upside. The valuation multiples reflect recognition of growth and profitability but also caution due to structural challenges and competitive pressures.

Valuation Metrics

Price to Earnings

20.40

TTM

Price to Sales

3.21

TTM

Price to Book

6.62

TTM

Enterprise Value to EBITDA

15.62

TTM

Enterprise Value to Revenue

4.00

TTM

 Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Price to Earnings12.3837.7731.2254.6817.46-154.6921.9727.12
Price to Sales14.0916.1416.1415.8711.6013.6410.2212.04
Price to Book8.509.449.968.587.458.356.717.49
Enterprise Value to EBITDA55.9175.7575.39102.7151.21280.5854.9384.33
Enterprise Value to Revenue16.8119.5019.4219.7114.1316.7813.2415.38

Sentiment & Analyst Ratings

Pulse
Pulse
Sentiment Analysis
MIXED

IBM's market sentiment remains broadly positive with a prevailing "Buy" consensus from analysts, driven by its strong positioning in AI, hybrid cloud, and quantum computing. However, recent price declines and bearish technical signals introduce caution, reflecting market concerns over competitive pressures and revenue uncertainties. Investor confidence is underpinned by anticipated acquisition synergies and steady free cash flow generation, but some uncertainty persists regarding the mainframe business and foreign exchange impact.

Analyst Recommendations

As of Apr 1, 2026
Strong SellSellHoldBuyStrong Buy
Hold
3.5 / 5.0
Based on 21 analyst ratings
Strong Sell
1
Sell
1
Hold
8
Buy
9
Strong Buy
2

Risk Assessment

Sentinel
Sentinel
Risk Assessment
MODERATE

IBM presents a moderate financial risk profile supported by stable earnings and a strategic focus on growth areas like AI and hybrid cloud, yet it contends with significant cybersecurity threats and leverage concerns. While liquidity ratios are below optimal thresholds, the company maintains adequate debt servicing ability, positioning it for sustained operations amid sector challenges. Market sentiment remains generally positive, with upside potential balanced against industry competition and macroeconomic uncertainties.

Liquidity & Solvency

Current Ratio

0.93

Latest Quarter: Q4 2025

Quick Ratio

0.90

Latest Quarter: Q4 2025

Debt-to-Equity

2.06

Latest Quarter: Q4 2025

Debt-to-Assets

0.44

Latest Quarter: Q4 2025

 Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Liquidity Metrics
Current Ratio0.930.930.911.011.041.061.121.13
Quick Ratio0.900.890.870.971.001.011.081.09
Solvency Metrics
Debt-to-Equity2.062.392.462.492.142.462.492.70
Debt-to-Assets0.440.450.460.460.430.450.450.46

Liquidity Assessment

Current Ratio: 0.93(Weak)

Quick Ratio: 0.90(Adequate)

The company has relatively weak liquidity and may face challenges meeting short-term obligations.

Solvency Assessment

Debt-to-Equity: 2.06(High)

Debt-to-Assets: 0.44(Moderate)

The company has relatively high debt levels, which may increase financial risk in economic downturns.

Frequently Asked Questions about IBM

AI Answers: Common Questions About IBM

Get AI-powered answers to the questions investors ask most about International Business Machines Corporation

IBM is not an ideal buy right now for short-term traders due to bearish technicals and a lack of bottoming signals, with the price at $230.76 well below key moving averages. The P/E of 20.7 is fair for its growth, and analyst targets suggest 18-35% upside, but waiting for technical stabilization or a pullback closer to $220 is prudent.

If you already own IBM, fundamentals remain strong and long-term prospects are positive, so selling is not necessary unless your timeframe is short-term or you need to manage risk. The technical downtrend could continue, but there is no fundamental deterioration warranting an exit for long-term holders.

The biggest risks are IBM's high leverage (debt/equity above 2, debt/assets over 44%), suboptimal liquidity ratios (current and quick ratios below 1), and the potential for further price declines given the bearish technical setup. Additionally, competition in AI/cloud and macroeconomic headwinds could pressure earnings.

Technical support is near $220.70 (52-week low), with resistance at $256.34 (50-day SMA) and $276.43 (200-day SMA). Analyst targets range from $279 to $330, implying 18-35% upside if IBM executes on growth and technicals recover.

IBM is fairly valued at a P/E of 20.7 and EV/EBITDA above historical averages, reflecting improved earnings but also market caution due to debt and legacy risks. The price-to-sales multiple is moderate, and valuation is in line with sector medians.

IBM's fundamentals are strong: revenue grew 7.6% in 2025, EPS jumped 76.7%, and gross margin is above 59%. Recurring revenue and high-value services drive growth, but liquidity and leverage should be monitored.

Technical analysis is bearish: IBM is in a Stage 4 decline, trading below all major moving averages with a death cross active. RSI is near 35, not yet oversold, and no reversal patterns are present; support is at $220.70.

Key catalysts include upcoming earnings reports (with a history of beats), further AI/cloud product launches, and successful integration of acquisitions. Macro events like interest rate changes and enterprise IT spending trends will also impact the outlook.

Want a Personalized Answer?

Get AI-powered insights tailored to your risk tolerance and investment goals.

More AI Stock Analyses